Key result
The tested formulation exhibited serious instability, with 17 of 26 samples failing and a mean loss of 17% (13% to 22%) after 4.8 months.
Key points are not available for this paper at this time.
No takes yet. Share an insight, caveat, or question.
Supports caution with this formulation's long-term stability; leaves open confirmatory testing before routine use.
Starr et al. (1998) studied this question. The tested formulation exhibited serious instability, with 17 of 26 samples failing and a mean loss of 17% (13% to 22%) after 4.8 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: